Avirmax, Inc. — Form D
Avirmax, Inc. of HAYWARD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-26. The offering totals $10.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-11-26
- Form: D
- Accession: 0001795165-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.0M
- Remaining: $7.0M
- Investors: 10
- Date of first sale: 2019-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-354271
Issuer
- Name: Avirmax, Inc.
- CIK: 0001795165
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 22421 HESPERIAN BLVD., HAYWARD, CA, 94541
- Phone: 408-601-7684
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Nancy Karen Chang | Director | Hayward, CA |
| Haifeng Chen | Director | Hayward, CA |
| Yu Karen Fang | Director | Hayward, CA |
| Qianye Karen Liu | Director | Hayward, CA |
| Shengjiang Liu | Director | Hayward, CA |
| Haifeng Chen | Executive Officer | Hayward, CA |
| Shengjiang Liu | Executive Officer | Hayward, CA |
More